Why the TPP Is Worse Than Mystery Meat By Paul Loeb

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
Why the TPP Is Worse Than Mystery Meat

By Paul Loeb
06/19/2015 10:56 pm EDT

Remember the World Trade Organization, which slipped into the shadows after massive Seattle protests in 1999? The same day last week that Congress initially blocked fast track authority for approval of the TPP trade agreement, the House voted to overturn rules requiring country-of-origin labeling for meat. Those supporting the latter said they were just responding to a World Trade Organization ruling, judging U.S. country-of-origin labeling unfair competition with meat coming from foreign countries like Canada and Mexico, and therefore a violation. They said they had no choice for fear of triggering sanctions or lawsuits from countries exporting meat across our borders.

I don't know about you, but I like knowing whether my meat comes from Iowa or Uzbekistan, Montana or Mexico, Kentucky or Kenya. So do 93 percent of Americans, according to a Consumer's Union survey. People like supporting U.S. farmers, cutting down distance travelled, knowing there will be at least minimal inspection standards, even if the delights of e-coli occasionally slip through. It seems commonsensical that we'd want at least the chance to become informed consumers, whether with the origins of our meat, GMO-derived crops, or the amount of sugar and calories in our baked goods.

Maybe the House members are wrong in insisting that the international tribunals that adjudicate trade disputes would deem this a violation. But if this particular House bill passes the Senate and gets signed by Obama, even the mere possibility of a lawsuit will have struck down a wholly reasonable law that protects our health and supports our local economies. And if TPP passes the Senate, other attempts to regulate commerce for the common good will be potentially gutted as well, from attempts at financial regulation to limits on the prices charged for drugs, to environmental rules and seemingly innocuous actions like requiring accurate labeling. Some of this could occur through legal action, and some through the mere fear that such action could occur.

Now maybe TPP won't contain rules on meat. Maybe it will simply limit other ways we might try to exert our sovereignty over critical choices that affect us. But we do know that this agreement, involving countries constituting 40 percent of the global economy, and that, through what's called the Investor-State Dispute Settlement process, it will establish unaccountable tribunals with the power to let corporations collect damages for loss of profits. We don't know the precise reach of the agreement because ordinary citizens haven't seen it. Even Congressional opponents were prohibited from taking notes when they looked at it, and "cleared advisors" who've seen it have been legally prohibited from talking specifics. Yet we're told it represents an inevitable future, that the benefits will trickle down to ordinary citizens, and that those who ask reasonable questions about its profound implications are merely obstructionist whiners.

So do we demand full transparency before moving ahead? Or do we trust that the corporations that negotiated these rules have our interests at heart, and would never, in the slightest, harm our democracy? Whether or not the country-of-origin labeling on meat survives or is ended by the House bill and WTO ruling, TPP plays for far larger stakes, the ground rules that affect our very potential to take common action. The meat bill is one more warning that there are some rules and agreements where we should be careful to eagerly swallow.

http://www.huffingtonpost.com/paul-loeb/will-...26130.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Enhancing Team Productivity: Key Tips for Salesforce Users

Updated Category Business Views 387

Enhancing Productivity for Salesforce Users Salesforce remains a cornerstone technology for countless businesses aiming to streamline customer relationship management processes. However, extracting the maximum value from Salesforce requires a deep understanding of its capabilities and a strategy tailored to maximize user productivity. This comprehensive guide provides...

Continue Reading
Burnett Homeopathy Hosts Global Experts for Historic Summit

Updated Category News Views 314

Burnett Homeopathy Summit 3 Unites Global Experts In a remarkable gathering, Burnett Homeopathy Pvt. Ltd. organized the much-anticipated World Homoeopathy Summit 3 in Köthen, Germany, which is often heralded as the epicenter of classical homeopathy. This significant event, celebrated around the birthday of Dr. Samuel Hahnemann, the Father of Homeopathy, saw the...

Continue Reading
Bioventus Inc. Engages at Global Healthcare Conference

Updated Category News Views 83

Bioventus to Participate in Healthcare Conference Bioventus Inc. (NASDAQ: BVS), a leading company focused on active healing innovations, is set to participate in a significant healthcare gathering. Mark Singleton, the esteemed Senior Vice-President and Chief Financial Officer of Bioventus, will participate in an engaging fireside chat at the upcoming Morgan Stanley Global...

Continue Reading
Shanghai Hosts Successful Dragon Boat Tournament with Global Teams

Updated Category News Views 265

The Thriving Dragon Boat Invitational Tournament in Shanghai The 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament wrapped up, boasting a remarkable record of participation. This vibrant event gathered numerous teams, showcasing the spirit of competition and camaraderie among the participants. A Record-Setting Participation This year's tournament saw the...

Continue Reading
Doubling Your Investment: A Look at Booz Allen Hamilton

Updated Category News Views 89

Doubling Your Investment: A Look at Booz Allen Hamilton Investing in the stock market can lead to considerable financial growth, especially when investors choose dynamic companies like Booz Allen Hamilton (NYSE: BAH). Over the past five years, this company's stock has significantly outperformed the market, delivering impressive returns for its shareholders. Understanding...

Continue Reading